Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Sales | 6.06 | 8.89 | 7.08 | 15.93 | 15.49 |
| Operating profit | -1.50 | -1.05 | -1.43 | 0.84 | 1.13 |
| Interest | 0.10 | 0.25 | 0.16 | 0.22 | 0.30 |
| Gross profit | -1.60 | -1.29 | -1.60 | 0.62 | 0.83 |
| EPS (Rs) | -1.64 | -1.19 | -0.64 | 0.15 | -0.27 |
Quarterly
results in details
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Other income | - | - | - | - | - |
| Stock adjustment | -1.13 | -0.77 | 0.58 | 2.34 | 3.86 |
| Raw material | 5.05 | 7.61 | 4.68 | 9.81 | 7.68 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.29 | 0.14 | 0.08 | 0.07 | 0.07 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.35 | 2.96 | 3.17 | 2.87 | 2.74 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.40 | 0.40 | 0.38 | 0.40 | 0.40 |
| Taxation | - | - | 0.12 | - | - |
| Net profit / loss | -2.34 | -1.69 | -0.91 | 0.22 | -0.39 |
| Extra ordinary item | -0.34 | - | 1.18 | - | -0.81 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 14.20 | 14.20 | 14.20 | 14.20 | 14.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -24.75 | -11.75 | -20.27 | 5.28 | 7.30 |
| GPM (%) | - | - | -22.54 | 3.90 | 5.35 |
| NPM (%) | - | - | -12.92 | 1.37 | -2.51 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis